|
KR20050034253A
|
|
Process for the preparation of ribofuranoside derivatives
|
|
KR20040090257A
|
|
Sulfur derivatives of 1-(2'-Fluoro-β-L-arabinofuranosyl)thymine and The process of preparing the same
|
|
KR20040065843A
|
|
Oral spray preparation of apomorphine hydrochloride
|
|
KR20030033819A
|
|
Sulfur derivatives of 2'-Fluoro-5-methyl-β-L-arabinopuranosyluridine
|
|
KR20030018802A
|
|
Sustained release tablet containing dried ferrous sulfate and L-glutamine as releasing controller
|
|
KR20030016834A
|
|
Process for preparing 1-methylhexahydro-4-azepinone hydrochloride
|
|
KR20020079198A
|
|
Toothpaste composition for prevention and/or treatment of sensitive teeth
|
|
KR20020078708A
|
|
The Novel Nucleotide Seguence of Hepatitis A Virus from Korean Patients
|
|
KR20020071235A
|
|
Compositions and preparations of silymarin complex with the improved bioavailability
|
|
KR20020064425A
|
|
Effervescent acetaminophen immediate release and modified release
|
|
KR20020064434A
|
|
Anthyroid controlled release system for methimazole and propylthiouracil
|
|
KR20020062028A
|
|
Double Coating Tablet
|
|
KR100449618B1
|
|
METHOD FOR PREPARING 2'-FLUORO-5-METHYL-β-L-ARABINOFURANOSYLURIDINE WITH IMPROVED STABILITY AND REDUCED COSTS
|
